The “Pediatric
Interventional Cardiology Market by Congenital Heart Defect
Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left
Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global
Forecasts to 2018” This report studies the global pediatric
interventional cardiology market over the forecast period of 2013 to 2018. This
market is valued at an estimated $894.7 million in 2013 and is poised to grow
at a CAGR of 9.0% from 2013 to 2018.
Browse more than 90 market data tables with 19
figures spread through 165 pages and in-depth TOC on "Pediatric
Interventional Cardiology Market ”
http://www.marketsandmarkets.com/Market-Reports/pediatric-interventional-cardiology-market-236831456.html Early buyers will receive 10%
customization on This reports.
Various new procedures
and interventional devices are being developed and launched in the market,
which is a major reason for the rapid growth of this market. Companies are
heavily investing in R&D, to develop new and advanced devices that cater to
the unmet needs of pediatric patients. Furthermore, the high growth potential
of the transcatheter heart valves market is another factor that is propelling
the growth of this market. Based on device type, the ASD, VSD, and PFO devices
market accounted for the largest share of 28% in 2013. However, the
transcatheter pulmonary valve market is poised to grow at the highest CAGR from
2013 to 2018.
On the basis of product, the
interventional cardiology market is segmented into angioplasty balloons,
angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque
modification devices, hemodynamic flow alteration devices, and accessories. The
angioplasty stents segment showcase high growth potential owing to
technological advancements, rising number of regulatory approvals, and
increasing investments by companies to develop new devices.
On the basis of type, the angioplasty
stents market is segmented into drug-eluting stents, bare-metal stents, and
bioabsorbable stents. The drug-eluting stents segment is projected to witness
the highest growth in this market due to increasing number of regulatory
approvals and new product launches.
On the basis of type, the catheters
market is segmented into IVUS/OCT, angiography catheters, and guiding
catheters. The IVUS/OCT segment is projected to witness the highest growth in
this market due to increasing penetration rates and rapid advancements &
innovations in these systems.
On the basis of type, the EVAR stent
grafts market is segmented into abdominal aortic aneurysms and thoracic aortic
aneurysms. The abdominal aortic aneurysms segment is projected to witness the
highest growth in this market due to rising incidence of smoking and
hypertension.
The Sample Report For This Report@
Geographically, the interventional
cardiology market is dominated by North America, followed by Europe, Asia, and
the Rest of the World (RoW). Growth in the North American region is primarily
driven by the rising incidence of cardiovascular diseases, rapidly growing
geriatric population, and technological advancements. However, the Asian market
is projected to grow at the highest CAGR during the forecast period.
Key players operating in the
interventional cardiology market include Abbott Laboratories (U.S.), Boston
Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis
Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo
Corporation (Japan).
Get The PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 5000 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our
850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high
growth markets following the "Growth Engagement Model – GEM". The GEM
aims at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this
year for their revenue planning and help them take their
innovations/disruptions early to the market by providing them research ahead of
the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701
Pike Street
Suite
2175, Seattle,
WA
98101, United States
Tel:
1-888-600-6441
No comments:
Post a Comment